Template:CLL Staging table: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{| | {| | ||
|+ Rai and Binet Staging System for CLL | |+ '''Rai and Binet Staging System for CLL''' | ||
|- | |-bgcolor="CEDFF2" | ||
! width=120px|Risk Stratification | ! width=120px|Risk Stratification | ||
! width=200px|Rai Stage | ! width=200px|Rai Stage | ||
| Line 9: | Line 9: | ||
| 0: Lymphocytosis only | | 0: Lymphocytosis only | ||
| A: <3 Lymphadenopathies | | A: <3 Lymphadenopathies | ||
|- | |-bgcolor="F5FAFF" | ||
| Intermediate risk | | Intermediate risk | ||
| I: Lymphadenopathy II: Organomegaly (splenomegaly/hepatomegaly) | | I: Lymphadenopathy II: Organomegaly (splenomegaly/hepatomegaly) | ||
Latest revision as of 14:56, 30 April 2019
| Risk Stratification | Rai Stage | Binet Stage |
|---|---|---|
| Low risk | 0: Lymphocytosis only | A: <3 Lymphadenopathies |
| Intermediate risk | I: Lymphadenopathy II: Organomegaly (splenomegaly/hepatomegaly) | B: >3 Lymphadenopathies |
| High risk | III: Anemia (hemoglobin <11 g/dL) IV: Thrombocytopenia (platelets <100 x 109/L) |
C: Hemoglobin <10 g/dL and/or platelets <100 x 109/L |
| Table Data [1] | ||
